Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome
| Autor: | Jyonouchi, Soma, Gwafila, Brenda, Gwalani, Lavesh A., Ahmad, Maria, Moertel, Chistopher, Holbert, Cecil, Kim, Ji Young, Kobrinsky, Nathan, Roy-Ghanta, Sumita, Orange, Jordan S. |
|---|---|
| Zdroj: | In Clinical Immunology June 2017 179:47-53 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect